FDA Inspection 1107819 — Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
The FDA completed an inspection of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. on Sep 13, 2019 in Hangzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 13, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hangzhou (China)